Search results
28 gru 2020 · Conclusions: Tall cell papillary carcinoma is the most frequent aggressive variant of papillary thyroid cancer. Tall cell histology represents an independent poor prognostic factor compared to conventional variants.
- Tall cell variant of papillary thyroid carcinoma: current evidence on ...
In one study, Ganly et al [4] found that PTC cases...
- Tall cell variant of papillary thyroid carcinoma: current evidence on ...
Prendiville and colleagues 21 compared a cohort of 20 TCV cases (undefined proportion) with a historic comparison (n = 1355) and concluded that tall cell histologic findings did not predict recurrence or survival, but that extrathyroid extension and higher stage were prognostic.
6 cze 2016 · In one study, Ganly et al [4] found that PTC cases containing 30%-49% tall cells and cases containing ≥ 50% tall cells have similar clinicopathologic features and survival, but both of them bear more aggressive features and poorer prognosis than PTC cases with < 30% tall cells.
Survival rates are grouped based on how far the cancer has spread, but your age and overall health, the type of thyroid cancer you have, how well the cancer responds to treatment, and other factors can also affect your outlook.
Thyroid cancerthyroid cancer consists of cancers of several different histologies, which differ in terms of cellular origin, incidence, and lethality [1]. The most common subtypes are well-differentiated carcinomas (i.e. papillary and follicular cancers), which arise from the follicular cells within the thyroid gland. Papillary and follicular thyroid cancers tend to have a more benign course ...
A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis. Oncotarget. 2017 Jan 24;8(4):6222-6232. doi: 10.18632/oncotarget.14055.
16 lip 2018 · Abstract. The subtype of the papillary thyroid carcinoma tall-cell variant has a worse prognosis than does the conventional papillary type (papillary thyroid carcinoma). The new World Health Organization 2017 classification defines a tall-cell variant as a tumour consisting of over 30% of cells that are two or three times as tall as they are wide.
